Search

  • Search


    Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital

    St James's Hospital

    Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital

    1. Competition notice published

      7. jan. kl. 14:507. januar 2025 kl. 14:50
    2. Tender submission deadline

      13. feb. kl. 12:0013. februar 2025 kl. 12:00
    3. Opening date

      13. feb. kl. 12:3013. februar 2025 kl. 12:30
    4. Tender validity period

      13. juni kl. 11:0013. juni 2025 kl. 11:00

    Brief

    Ireland: Tenders/St James's Hospital/Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital

    Expired

    The competition has expired without a winner being announced.

    Brief

    Farmasøytisk engroshandel

    The CA is tendering for the Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2025

    About the bid

      The CA is tendering for the Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital, the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Authority (CA) 2025

      Contact phone
      014103000
      Contact email
      dgunning@stjames.ie
      Address
      James Street, D08 NHY1 Dublin

    Custom Assessment Criteria

    Start a free trial to ask your own questions about the tender and get AI-generated answers.

    Award Criteria

      Found no award criteria in the contract notice.

    Qualification requirements

      Found no qualification requirements in the contract notice.

    Previous Contract Winners

    Start a free trial to see who has won similar tenders for this buyer.

    See the full notice

    Contracting authority
    St James's Hospital
    Title
    Provision of Extended Half-Life Recombinant Factor IX for St James’s Hospital
    Type
    CompetitionPrequalification
    Main code
    33141530Blood coagulants
    Supplemental codes
    33141510Blood products33141570Human blood33194220Blood-transfusion supplies33600000Pharmaceutical products
    Location
    Dublin
    Estimated value
    €22,000,000.00

    Active similar competitions

    • St James's Hospital

      Laboratorie- og analyseutstyr

      The Provision of a Coagulation Analytical Platform for the St James’s Hospital Coagulation Laboratory incorporating the National Centre for Hereditary Coagulation Disorders. at St James’s Hospital.

      St James's Hospital needs a coagulation analytical platform for the St James’s Hospital Coagulation Laboratory, incorporating the National Centre for Hereditary Coagulation Disorders, for 7 years, with a maximum total value of 4,550,000 EUR. The goods are to be delivered in Dublin, Ireland.

      Competition23. sep. 2026
      28. okt. 2026(17 days)
      €4,550,000
    • St James's Hospital

      Laboratorie- og analyseutstyr

      Invitation to tender for the provision of a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

      St James's Hospital needs a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department in Dublin for 60 months, with a maximum total value of 1,850,000 EUR. BioSciences Limited a Thermo Fisher Company likely has a similar contract today.

      Competition24. sep. 2026
      29. okt. 2026(18 days)
      €1,850,000
    • St James's Hospital

      Invitation to tender for the Provision of a Digital PCR Platform, Associated Reagents and Support for Cancer Molecular Diagnostics Department within St James’s Hospital Dublin

      St James's Hospital needs a digital PCR platform, including all hardware, software, and ancillary equipment, along with associated reagents and support, for its Cancer Molecular Diagnostics Department in Dublin. The contract duration is 54 months, with a maximum total value of 250,000 EUR. The purchase includes a minimum three-year comprehensive warranty, installation, commissioning, and training. The platform will be used for assay development, evaluation, and method transfer, with an agreed quantity/value of development reagents and consumables to be drawn down over the three-year agreement.

      Competition8. okt. 2026
      10. nov. 2026(30 days)
      €250,000